Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Japanese launch for GSK's dutasteride for benign prostatic hyperplasia

Sep. 7, 2009

Light Sciences Oncology treats patients in phase II Aptocine trial in BPH

Aug. 20, 2009

Sitaxsentan treatment has multiple benefits in chronic kidney disease

Aug. 20, 2009

AEterna reports results from two phase III cetrorelix studies in BPH

Aug. 18, 2009

Hisamitsu reports results from phase II study of HOB-294 in overactive bladder

Aug. 11, 2009

Spectrum acquires full rights and intellectual property to Altair's RenaZorb in all fields

Aug. 11, 2009

Lilly discovers new MR antagonists for chronic kidney disease therapy

Aug. 11, 2009

Mirabegron does not affect PK, PD and safety profiles of metformin in healthy adults

Aug. 7, 2009

Kringle concludes dosing and safety evaluation in phase Ia trial of rhHGF in renal disease

Aug. 6, 2009

The European Commission approves Otsuka's Samsca

Aug. 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...